Sign in Subscribe
COVID-19

Autologous Cell Therapy Market to Grow by 22% from 2020-2024

Strategic Insights

— 1 min read

The autologous cell therapy market is expected to grow by USD 1.97 billion during 2020-2024, progressing at a CAGR of 22% during the forecast period. The market is driven by the increasing demand for effective drugs for cardiac and degenerative disorders. The use of biomass as a fuel in boiler is also a key factor driving the market growth.

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Bayer AG, Brainstorm Cell Therapeutics Inc., Daiichi Sankyo Co. Ltd., FUJIFILM Holdings Corp., Holostem Terapie Avanzate Srl, Osiris Therapeutics Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Sumitomo Chemical Co. Ltd., and Vericel Corp. are some of the major market participants. The market is expected to grow in the North American region, with the year-over-year growth rate estimated at 21.70% in 2020.

Key Takeaways:

  • The market is expected to grow at a CAGR of 22% during the forecast period 2020-2024, with the market size reaching USD 1.97 billion.
  • The key factor driving the market is the increasing demand for effective drugs for cardiac and degenerative disorders.
  • The use of biomass as a fuel in boiler is instrumental in driving the growth of the market.
  • The market is fragmented, with vendors such as Bayer AG, Brainstorm Cell Therapeutics Inc., Daiichi Sankyo Co. Ltd., FUJIFILM Holdings Corp., Holostem Terapie Avanzate Srl, Osiris Therapeutics Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Sumitomo Chemical Co. Ltd., and Vericel Corp. operating in the market.
  • The North American region is expected to hold the highest market share, with the year-over-year growth rate estimated at 21.70% in 2020.
  • The major trend of the market is the increasing demand for effective drugs for cardiac and degenerative disorders.
  • The market is expected to grow in the forecast period, with the market size reaching USD 1.97 billion.

Statistics:

  • CAGR of the market during the forecast period 2020-2024: 22%
  • Market size in 2019: $10.3 billion
  • Year-over-year growth rate in 2020: 21.70%
  • Market growth rate: Accelerating

Sources:

  • Technavio. "Autologous Cell Therapy Market 2020-2024." Business Wire, 2 Sept. 2020, https://www.businesswire.com/news/home/20200902005621/en/.
  • Technavio. "Autologous Cell Therapy Market 2020-2024: Segmentation." Business Wire, 2 Sept. 2020, https://www.businesswire.com/news/home/20200902005621/en/.

Read more